2017 Federal Circuit Obviousness Decisions in Biopharma: 5 Takeaways

June 4, 2026

The Empty Chair in Antitrust Conspiracy Cases

On June 4, associate Matthew Levinton will moderate the American Bar Association webinar, "The Empty Chair in Antitrust Conspiracy Cases."

Webinar

Antitrust

June 4, 2026

USC Gould/Analysis Group Global Competition Law Thought Leadership Conference

Axinn partner Jacklin Chou Lem will speak on the "Algorithmic Pricing/Collusion" panel at the USC/Analysis Group Global Competition Law Thought Leadership Conference, being held June 4 in Los Angeles, CA.

Speaking Engagement

Antitrust

June 2 -3, 2026

17th ACI Summit on Biosimilars & Innovator Biologics

Axinn partners Rebecca Clegg and Matt Murphy will speak at American Conference Institute’s Summit on Biosimilars & Innovator Biologics, being held June 2-3 in New York.

Speaking Engagement

Intellectual Property

June 2 -3, 2026

GCR Live: Europe 2026

On June 3, Axinn partners Bradley Justus and Mary Helen Wimberly will speak at the Global Competition Review’s Live: Europe 2026, being held on June 2-3 in Brussels.

Speaking Engagement

Antitrust

May 28-29, 2026

20th Annual IBA Competition Mid-Year Conference

On May 29, Axinn partner Bradley Justus will speak on a panel entitled, “Digital economy enforcement with a focus on data and AI" at the International Bar Association’s Competition Mid-Year Conference, being held May 28-29 in Amsterdam.

Speaking Engagement

Antitrust

May 22, 2026

Axinn Partners Named to Lawdragon 500 Leading Global Litigators 2026

Axinn is pleased to announce that Lawdragon has recognized ten partners in its “500 Leading Global Litigators” guide for 2026. The attorneys recognized were selected through submissions, research, and vetting with the leading trial lawyers.

News

Litigation & Trials

May 21, 2026

Turning Up the Heat: Federal Circuit Sets the Temperature for pH Measurements in Precedential Opinion

The Federal Circuit recently affirmed a Northern District of West Virginia decision finding no literal or doctrine of equivalents...

Axinn Viewpoints

Intellectual Property

May 19, 2026

Axinn Represents Tecomet in Closing of Merger with Orchid Orthopedic

Axinn represented Tecomet, together with its sponsor Charlesbank, as antitrust counsel in Tecomet’s combination with Orchid Orthopedic Solutions, forming a scaled global manufacturing partner serving MedTech and Aerospace & Defense customers. The transaction closed on May 14, 2026.

Deals & Cases

Antitrust

May 19, 2026

Recent Benchmarking Suits Highlight DOJ Enforcement Risks

Axinn partners Lindsey Strang Aberg and Tiffany Rider co-authored the Law360 article, "Recent Benchmarking Suits Highlight DOJ Enforcement Risks."

Byline Articles

Antitrust

May 18, 2026

“Old Crime, New Code” – DOJ Outlines its Views on When Software and AI Can Facilitate Collusion

Last week at a conference chaired by the head of Axinn’s West Coast antitrust practice, Antitrust Division Criminal Deputy Daniel Glad...

Axinn Viewpoints

Antitrust

May 14, 2026

From Listings to Litigation: Zillow and Redfin Face Continued Litigation with the FTC and States

On May 6, 2026, Judge Anthony Trenga of the U.S. District Court for the Eastern District of Virginia denied Zillow and Redfin’s motion to...

Axinn Viewpoints

Antitrust

May 13-14, 2026

Informa CompLaw Antitrust West Coast Conference 2026

Axinn partners Daniel Bitton and Katrina Rouse will speak at Informa’s CompLaw Antitrust West Coast Conference, being held May 13-14 in San Francisco. Daniel will also serve as conference chair.

Speaking Engagement

Antitrust

2017 Federal Circuit Obviousness Decisions in Biopharma: 5 Takeaways

Related People

Related Services

Featured Insights

Featured Insights